David Giegel is currently the Vice President of Molecular Sciences at Armonica Technologies, Inc. and a Chief Scientific Officer at August Therapeutics, Inc. In the past, David co-founded TissueNetix, Inc., served on the Scientific Advisory Board of Nanomedical Diagnostics, Inc. and was a President at MicroStem. David has a Ph.D. in Biological Chemistry from the University of Michigan and a B.S. in Chemistry from Miami University.
Location
San Diego, United States